Physician profile
Preethi Krishnan
NPI 1790904134
$701.55
in general payments reported to CMS, 2019-2025
8 companies · $69.43 in 2025
The $69.43 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2022: $213 · 2023: $118 · 2024: $181 · 2025: $69.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $367.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $187.04 | 2022-2024 | Tepezza |
| Medtronic Minimed, INC. | $120.42 | 2019 | |
| Mannkind Corporation | $118.65 | 2024 | |
| Xeris Pharmaceuticals, INC. | $117.73 | 2023 | Gvoke Hypopen |
| Lilly USA, LLC | $75.76 | 2022 | |
| Novo Nordisk INC | $37.44 | 2025 | Ozempic |
| Glaxosmithkline, LLC. | $26.31 | 2022-2025 | Shingrix, Arexvy |
| Radius Health, INC. | $18.20 | 2025 | Tymlos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Preethi Krishnan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.